(Q35023530)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12477430%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

review article

1 reference

title

Do not underestimate the power of antibodies--lessons from adoptive transfer of antibodies against HIV (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12477430%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12477430%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

Robert A Rasmussen

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12477430%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

Regina Hofmann-Lehmann

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12477430%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

Weidong Xu

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12477430%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

Harold M McClure

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12477430%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

Ruth M Ruprecht

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12477430%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

language of work or name

English

0 references

publication date

1 December 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12477430%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12477430%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

volume

20 Suppl 4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12477430%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

page(s)

A61-5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12477430%20AND%20SRC:MED&resulttype=core&format=json

Neutralizing antibodies against HIV -- back in the major leagues?

15 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900389-4

7 January 2021

Neutralization of primary human immunodeficiency virus type 1 isolates by the broadly reactive anti-V3 monoclonal antibody, 447-52D

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900389-4

7 January 2021

Additive Effects Characterize the Interaction of Antibodies Involved in Neutralization of the Primary Dualtropic Human Immunodeficiency Virus Type 1 Isolate 89.6

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900389-4

7 January 2021

Potent and synergistic neutralization of human immunodeficiency virus (HIV) type 1 primary isolates by hyperimmune anti-HIV immunoglobulin combined with monoclonal antibodies 2F5 and 2G12.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900389-4

7 January 2021

Human neutralizing monoclonal antibodies of the IgG1 subtype protect against mucosal simian-human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900389-4

7 January 2021

Broadly neutralizing antibodies targeted to the membrane-proximal external region of human immunodeficiency virus type 1 glycoprotein gp41.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900389-4

7 January 2021

Neutralization synergy of human immunodeficiency virus type 1 primary isolates by cocktails of broadly neutralizing antibodies.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900389-4

7 January 2021

A potent cross-clade neutralizing human monoclonal antibody against a novel epitope on gp41 of human immunodeficiency virus type 1.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900389-4

7 January 2021

Protection of Macaques against pathogenic simian/human immunodeficiency virus 89.6PD by passive transfer of neutralizing antibodies.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900389-4

7 January 2021

Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900389-4

7 January 2021

Postnatal passive immunization of neonatal macaques with a triple combination of human monoclonal antibodies against oral simian-human immunodeficiency virus challenge

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900389-4

7 January 2021

Antibody protects macaques against vaginal challenge with a pathogenic R5 simian/human immunodeficiency virus at serum levels giving complete neutralization in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900389-4

7 January 2021

A chimeric simian/human immunodeficiency virus expressing a primary patient human immunodeficiency virus type 1 isolate env causes an AIDS-like disease after in vivo passage in rhesus monkeys.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900389-4

7 January 2021

Infection and pathogenicity of chimeric simian-human immunodeficiency viruses in macaques: determinants of high virus loads and CD4 cell killing

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900389-4

7 January 2021

Postnatal pre- and postexposure passive immunization strategies: protection of neonatal macaques against oral simian-human immunodeficiency virus challenge

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900389-4

7 January 2021

Immunologic control of HIV-1.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900389-4

7 January 2021

Dramatic rise in plasma viremia after CD8(+) T cell depletion in simian immunodeficiency virus-infected macaques.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900389-4

7 January 2021

A nonhuman primate model for the selective elimination of CD8+ lymphocytes using a mouse-human chimeric monoclonal antibody.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900389-4

7 January 2021

Control of viremia and prevention of clinical AIDS in rhesus monkeys by cytokine-augmented DNA vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900389-4

7 January 2021

Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900389-4

7 January 2021

Quantifying the uncertainty in forecasts of anthropogenic climate change

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900389-4

7 January 2021

Eventual AIDS vaccine failure in a rhesus monkey by viral escape from cytotoxic T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900389-4

7 January 2021

Disquisitions of Original Antigenic Sin. I. Evidence in man

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900389-4

7 January 2021

Deceptive imprinting: insights into mechanisms of immune evasion and vaccine development

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900389-4

7 January 2021

Antibody and cellular immune responses in breakthrough infection subjects after HIV type 1 glycoprotein 120 vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900389-4

7 January 2021

Deceptive imprinting: a cosmopolitan strategy for complicating vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900389-4

7 January 2021

Heterologous neutralizing antibody induction in a simian-human immunodeficiency virus primate model: lack of original antigenic sin.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900389-4

7 January 2021

Human immunodeficiency virus type 1 infection despite prior immunization with a recombinant envelope vaccine regimen

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900389-4

7 January 2021

DNA prime/protein boost vaccine strategy in neonatal macaques against simian human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900389-4

7 January 2021

Human monoclonal antibody 2G12 defines a distinctive neutralization epitope on the gp120 glycoprotein of human immunodeficiency virus type 1

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900389-4

7 January 2021

10.1016/S0264-410X(02)00389-4

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12477430%20AND%20SRC:MED&resulttype=core&format=json

release_nqk47njmw5bhlilpe7oythnwmi

15 December 2019

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/nqk47njmw5bhlilpe7oythnwmi

24 November 2022

mapped directly with Wikidata item

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12477430%20AND%20SRC:MED&resulttype=core&format=json